Preferential accumulation of amyloid-beta in presynaptic glutamatergic terminals (VGluT1 and VGluT2) in Alzheimer's disease cortex
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, APP undergoes BACE1-mediated cleavage during anterograde axonal transport, and Aβ can be generated and released at or near presynaptic sites in vivo[19,23-27].”
From Axonal BACE1 dynamics and targeting in hippocampal neurons: a role for Rab11 GTPase (2014) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769 · cited 1×
“In this report, the Aβ assembly states associated with VGluT1-2 are more likely to be a 56 kD oligomeric species and small oligomers b20 kD, which are prominent in synaptic terminals (Fein et al., 2008; Lesné et al., 2006; Sokolow et al., in press).”
RetractedAlzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Alzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1119 · Cited by 2,168
Buckner, R. L., Snyder, A. Z., Shannon, B. J., LaRossa, G., Sachs, R., Fotenos, A. F., Sheline, Y. I., Klunk, W. E., Mathis, C. A., Morris, J. C., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2177-05.2005 · Cited by 2,140
Palop, J. J., Chin, J., Roberson, E. D., Wang, J., Thwin, M. T., Bien-Ly, N., Yoo, J., Ho, K. O., Yu, G.-Q., Kreitzer, A., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.07.025 · Cited by 1,653
Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks
Palop, J. J., & Mucke, L. (2010) · Nature Neuroscience · doi:10.1038/nn.2583 · Cited by 1,651 · cited 1×
“Indeed, unusual patterns of neuronal activity, such as reduced glutamatergic excitatory currents and increased proportion of hyperactive and hypoactive neurons were reported in mouse models of AD (Busche et al., 2008; Palop et al., 2007; Palop and Mucke, 2010).”
Shankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592
Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive Decline
Näslund, J. (2000) · JAMA · doi:10.1001/jama.283.12.1571 · Cited by 1,268
Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo
Cirrito, J. R., Yamada, K. A., Finn, M. B., Sloviter, R. S., Bales, K. R., May, P. C., Schoepp, D. D., Paul, S. M., Mennerick, S., & Holtzman, D. M. (2005) · Neuron · doi:10.1016/j.neuron.2005.10.028 · Cited by 1,265
Lacor, P. N., Buniel, M. C., Furlow, P. W., Sanz Clemente, A., Velasco, P. T., Wood, M., Viola, K. L., & Klein, W. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3501-06.2007 · Cited by 1,188 · cited 1×
“Several studies reported the co-localization of Aβ with postsynaptic NMDA-receptors (Dewachter et al., 2009; Lacor et al., 2007) but it remains unclear whether Aβ is present within presynaptic glutamatergic terminals.”
Takamori, S., Rhee, J. S., Rosenmund, C., & Jahn, R. (2000) · Nature · doi:10.1038/35025070 · Cited by 862
Picomolar Amyloid-β Positively Modulates Synaptic Plasticity and Memory in Hippocampus
Puzzo, D., Privitera, L., Leznik, E., Fà, M., Staniszewski, A., Palmeri, A., & Arancio, O. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2692-08.2008 · Cited by 740
Endocytosis Is Required for Synaptic Activity-Dependent Release of Amyloid-β In Vivo
Cirrito, J. R., Kang, J.-E., Lee, J., Stewart, F. R., Verges, D. K., Silverio, L. M., Bu, G., Mennerick, S., & Holtzman, D. M. (2008) · Neuron · doi:10.1016/j.neuron.2008.02.003 · Cited by 635
Water-soluble Aβ(N-40, N-42) oligomers in normal and Alzheimer disease brains
Kuo, Y.-M., Emmerling, M. R., Vigo-Pelfrey, C., Kasunic, T. C., Kirkpatrick, J. B., Murdoch, G. H., Ball, M. J., & Roher, A. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.8.4077 · Cited by 618
Amyloid-β Dynamics Correlate with Neurological Status in the Injured Human Brain
Brody, D. L., Magnoni, S., Schwetye, K. E., Spinner, M. L., Esparza, T. J., Stocchetti, N., Zipfel, G. J., & Holtzman, D. M. (2008) · Science · doi:10.1126/science.1161591 · Cited by 295
Synaptic Changes in Alzheimer's Disease
Gylys, K. H., Fein, J. A., Yang, F., Wiley, D. J., Miller, C. A., & Cole, G. M. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63436-0 · Cited by 253
Self-citationWilliams, C., Mehrian Shai, R., Wu, Y., Hsu, Y.-H., Sitzer, T., Spann, B., McCleary, C., Mo, Y., & Miller, C. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004936 · Cited by 116
Self-citation
Research works printed but not linked: 30
- Abramov, 2009, Amyloid-beta as a positive endogenous regulator of release probability at hippocampal synapses, Nat. Neurosci., 12, 1567, 10.1038/nn.2433 · DOI · Paper page
- Bell, 2007, Paradoxical upregulation of glutamatergic presynaptic boutons during mild cognitive impairment, J. Neurosci., 27, 10810, 10.1523/JNEUROSCI.3269-07.2007 · DOI
- Busche, 2008, Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease, Science, 321, 1686, 10.1126/science.1162844 · DOI · Paper page
- Cowburn, 1988, Presynaptic and postsynaptic glutamatergic function in Alzheimer's disease, Neurosci. Lett., 86, 109, 10.1016/0304-3940(88)90192-9 · DOI
- Cross, 1987, Sodium dependent d-[3H]aspartate binding in cerebral cortex in patients with Alzheimer's and Parkinson's diseases, Neurosci. Lett., 79, 213, 10.1016/0304-3940(87)90699-9 · DOI
- Dewachter, 2009, Deregulation of NMDA-receptor function and down-stream signaling in APP[V717I] transgenic mice, Neurobiol. Aging, 30, 241, 10.1016/j.neurobiolaging.2007.06.011 · DOI
- Dodd, 1986, Optimization of freezing, storage, and thawing conditions for the preparation of metabolically active synaptosomes from frozen rat and human brain, Mol. Chem. Neuropathol., 4, 177
- Fein, 2008, Co-localization of amyloid beta and tau pathology in Alzheimer's disease synaptosomes, Am. J. Pathol., 172, 1683, 10.2353/ajpath.2008.070829 · DOI · Paper page
- Fremeau, 2004, Vesicular glutamate transporters 1 and 2 target to functionally distinct synaptic release sites, Science, 304, 1815, 10.1126/science.1097468 · DOI · Paper page
- Gylys, 2000, Quantitative characterization of crude synaptosomal fraction (P-2) components by flow cytometry, J. Neurosci. Res., 61, 186, 10.1002/1097-4547(20000715)61:2<186::AID-JNR9>3.0.CO;2-X · DOI
- Gylys, 2004, Enrichment of presynaptic and postsynaptic markers by size-based gating analysis of synaptosome preparations from rat and human cortex, Cytometry A, 60, 90, 10.1002/cyto.a.20031 · DOI
- Gylys, 2007, Increased cholesterol in Abeta-positive nerve terminals from Alzheimer's disease cortex, Neurobiol. Aging, 28, 8, 10.1016/j.neurobiolaging.2005.10.018 · DOI
- Hardy, 1987, Region-specific loss of glutamate innervation in Alzheimer's disease, Neurosci. Lett., 73, 77, 10.1016/0304-3940(87)90034-6 · DOI
- Herzog, 2001, The existence of a second vesicular glutamate transporter specifies subpopulations of glutamatergic neurons, J. Neurosci., 21, 181RC-, 10.1523/JNEUROSCI.21-22-j0001.2001 · DOI · Paper page
- Kabogo, 2010, [beta]-Amyloid-related peptides potentiate K+ −evoked glutamate release from adult rat hippocampal slices, Neurobiol. Aging, 31, 1164, 10.1016/j.neurobiolaging.2008.08.009 · DOI
- Kashani, 2008, Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease, Neurobiol. Aging, 29, 1619, 10.1016/j.neurobiolaging.2007.04.010 · DOI · Paper page
- Kim, 2010, Group II metabotropic glutamate receptor stimulation triggers production and release of Alzheimer's amyloid(beta)42 from isolated intact nerve terminals, J. Neurosci., 30, 3870, 10.1523/JNEUROSCI.4717-09.2010 · DOI
- Kirvell, 2006, Down-regulation of vesicular glutamate transporters precedes cell loss and pathology in Alzheimer's disease, J. Neurochem., 98, 939, 10.1111/j.1471-4159.2006.03935.x · DOI · Paper page
- Kirvell, 2010, Vesicular glutamate transporter and cognition in stroke: a case-control autopsy study, Neurology, 75, 1803, 10.1212/WNL.0b013e3181fd6328 · DOI
- Li, 2009, Soluble oligomers of amyloid [beta] protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake, Neuron, 62, 788, 10.1016/j.neuron.2009.05.012 · DOI · Paper page
- McCullumsmith, 2003, Expression of transcripts for the vesicular glutamate transporters in the human medial temporal lobe, Ann. N. Y. Acad. Sci., 1003, 438, 10.1196/annals.1300.046 · DOI
- McLean, 1999, Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease, Ann. Neurol., 46, 860, 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M · doi:10.1002/1531-8249(199912)46:6<860::aid-ana8>3.0.co;2-m
- Minkeviciene, 2008, Age-related decrease in stimulated glutamate release and vesicular glutamate transporters in APP/PS1 transgenic and wild-type mice, J. Neurochem., 105, 584, 10.1111/j.1471-4159.2007.05147.x · DOI · Paper page
- Pratt, 2011, A novel role for {gamma}-secretase: selective regulation of spontaneous neurotransmitter release from hippocampal neurons, J. Neurosci., 31, 899, 10.1523/JNEUROSCI.4625-10.2011 · DOI
- Procter, 1988, Evidence of glutamatergic denervation and possible abnormal metabolism in Alzheimer's disease, J. Neurochem., 50, 790, 10.1111/j.1471-4159.1988.tb02983.x · DOI · Paper page
- Proctor, 2011, Post-synaptic scaffolding protein interactions with glutamate receptors in synaptic dysfunction and Alzheimer's disease, Prog. Neurobiol., 93, 509, 10.1016/j.pneurobio.2011.02.002 · DOI
- Sokolow, S., et al., in press. AD synapses contain abundant Abeta monomer and multiple soluble oligomers, including a 56-kDa assembly. Neurobiol. Aging. doi:10.1016/j.neurobiolaging.2011.05.011. · DOI
- Terry, 1991, Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment, Ann. Neurol., 30, 572, 10.1002/ana.410300410 · DOI · Paper page
- Varoqui, 2002, Identification of the differentiation-associated Na+/PI transporter as a novel vesicular glutamate transporter expressed in a distinct set of glutamatergic synapses, J. Neurosci., 22, 142, 10.1523/JNEUROSCI.22-01-00142.2002 · DOI · Paper page
- Walsh, 2002, Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo, Nature, 416, 535, 10.1038/416535a · DOI · Paper page
Cited by
Revett, T. J., Baker, G. B., Jhamandas, J., & Kar, S. (2013) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.110190 · Cited by 292
de Wilde, M. C., Overk, C. R., Sijben, J. W., & Masliah, E. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.12.005 · Cited by 278
Ghatak, S., Dolatabadi, N., Trudler, D., Zhang, X., Wu, Y., Mohata, M., Ambasudhan, R., Talantova, M., & Lipton, S. A. (2019) · eLife · doi:10.7554/elife.50333 · Cited by 227
Axonal BACE1 dynamics and targeting in hippocampal neurons: a role for Rab11 GTPase
Buggia-Prévot, V., Fernandez, C. G., Riordan, S., Vetrivel, K. S., Roseman, J., Waters, J., Bindokas, V. P., Vassar, R., & Thinakaran, G. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-1 · Cited by 214
Biesemann, C., Grønborg, M., Luquet, E., Wichert, S. P., Bernard, V., Bungers, S. R., Cooper, B., Varoqueaux, F., Li, L., Byrne, J. A., et al. (2014) · The EMBO Journal · doi:10.1002/embj.201386120 · Cited by 156
Metadata
- Authors
- Sokolow, S., Luu, S. H., Nandy, K., Miller, C. A., Vinters, H. V., Poon, W. W., & Gylys, K. H.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2012-01
- Volume
- 45
- Issue
- 1
- Pages
- 381-387
- ISSN
- 0969-9961
- Cited by
- 78
- References
- 18
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Funders
- NIH (AG27465, CA16042, AI 28697)
- NIA (AG18879)
- Daljit S. and Elaine Sarkaria Chair in Diagnostic Medicine
- JCCC
- UCLA AIDS Institute
- David Geffen School of Medicine
- Chancellor's Office at UCLA
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.